Turning Proposal Strategy into a Learnable Competitive Advantage
Convert RFPs into Awarded Clinical Trials
Turning Proposal Strategy into a Learnable Competitive Advantage
WHAT WE DO
Technical capability alone does not win business
The Clinical Trial Education Institute, LLC (CTEl) is a specialized education and advisory firm helping clinical research organizations, biotechnology companies, and pharmaceutical teams compete more effectively for clinical development opportunities.
Clients must believe that a prospective partner understands their development objectives, anticipates their risks, aligns its people around a compelling strategy, and can execute with confidence. Yet many highly capable organizations struggle to translate their experience into persuasive proposals, differentiated value stories, and cohesive bid-defense performances. CTEI helps close that gap.
HOW WE DO IT
Our Proposal Strategy Bootcamp
Our Proposal Strategy Bootcamp
Our Proposal Strategy Bootcamp
A practical, team-based program that strengthens opportunity qualification, competitive positioning, win-theme development, proposal planning, and sponsor-centered storytelling.
Our Bid Defense Readiness Lab
Our Proposal Strategy Bootcamp
Our Proposal Strategy Bootcamp
An immersive preparation experience that helps teams sharpen executive presence, align cross-functional messaging, anticipate sponsor questions, and perform with confidence under pressure.
Our Quote-to-Cash Advisory Sprint
Our Bid Defense Crash Course for Junior Team Members
Our Bid Defense Crash Course for Junior Team Members
A focused RFP-to-Win advisory engagement supporting active, high-value pursuits by strengthening strategy, proposal messaging, and bid-defense readiness.
Our Bid Defense Crash Course for Junior Team Members
Our Bid Defense Crash Course for Junior Team Members
Our Bid Defense Crash Course for Junior Team Members
A 2-6 hour, online, self-paced course offering that prepares junior team members for the 1st or 2nd bid defense meeting of their careers.
WHO WE ARE
Your CTEI Team
Christopher Morley, MPH
Christopher Morley, MPH
Over the past 2+ decades the CTEI team has become one of the CRO industry’s most relied-upon therapeutic subject matter experts for clinical services RFPs and bid defense strategy. They have led or contributed to more than 1000 RFPs, reviewed over 700 clinical protocols, and served as the lead clinical strategist in more than 280 bid defe
Over the past 2+ decades the CTEI team has become one of the CRO industry’s most relied-upon therapeutic subject matter experts for clinical services RFPs and bid defense strategy. They have led or contributed to more than 1000 RFPs, reviewed over 700 clinical protocols, and served as the lead clinical strategist in more than 280 bid defense meetings—directly influencing revenue growth and award outcomes for employers in excess of $700 million of revenue. Their specialization in early-late phase, study design, feasibility optimization, competitive landscape analysis, and patient recruitment strategy has equipped both CROs and biotech sponsors with high-impact guidance that strengthens proposals, elevates client confidence, and improves win probability. Through CTEI the team now delivers this same level of precision, insight, and strategic clarity to clients navigating today’s complex global clinical trial environment.
Christopher Morley, MPH
Christopher Morley, MPH
Christopher Morley, MPH
Christopher brings 25 years of clinical research industry experience across both clinical development strategy and operations. For well over a decade he has managed and led bidding and operational teams across the spectrum of the RFP process. Spanning operational roles from Clinical Research Associate up to Portfolio Director across biote
Christopher brings 25 years of clinical research industry experience across both clinical development strategy and operations. For well over a decade he has managed and led bidding and operational teams across the spectrum of the RFP process. Spanning operational roles from Clinical Research Associate up to Portfolio Director across biotech and pharmaceutical programs in multiple therapeutic areas and treatment modalities, he has seen the nuances of how delivery teams find success through strong planning, risk mitigation, and team coordination at all levels. Christopher holds a MPH from Emory University and a BS from Georgia State University. Prior to his work in clinical research, Christopher proudly served in the United States Marine Corps.
Nathan Currier, PhD
Christopher Morley, MPH
Nathan Currier, PhD
Dr. Currier brings more than 28 years of cross-sector experience spanning pre-clinical research, clinical development, biotechnology, NGOs, and academic oncology. With a PhD in cellular and molecular biology from McGill University, his academic work centered on NK-cell-mediated amelioration of erythroleukemia (Di Guglielmo Syndrome). Acro
Dr. Currier brings more than 28 years of cross-sector experience spanning pre-clinical research, clinical development, biotechnology, NGOs, and academic oncology. With a PhD in cellular and molecular biology from McGill University, his academic work centered on NK-cell-mediated amelioration of erythroleukemia (Di Guglielmo Syndrome). Across his career, he has contributed to fundamental oncology research, pediatric neuroblastoma studies involving radioligand modalities, and executive-level clinical strategy roles guiding global development programs. His expertise bridges scientific rigor, operational execution, and strategic leadership across the full continuum of oncology research.